| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/26/2011 | WO2011062974A1 Drug-loaded fibers |
| 05/26/2011 | WO2011062936A2 Self-assembled toroidal-spiral particles and manufacture and uses thereof |
| 05/26/2011 | WO2011062927A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity |
| 05/26/2011 | WO2011062906A2 Treatment of atrial fibrillation |
| 05/26/2011 | WO2011062903A2 Slow infusion of sulcardine and its salts |
| 05/26/2011 | WO2011062503A1 Parenteral formulations of gemcitabine derivatives |
| 05/26/2011 | WO2011062420A2 Nanoparticles for tumor-targeting and processes for the preparation thereof |
| 05/26/2011 | WO2011062255A1 Process for production of liposome through two-stage emulsification using mixed organic solvent as oily phase |
| 05/26/2011 | WO2011062244A1 Carrier, method for producing same, and applications of same |
| 05/26/2011 | WO2011062217A1 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same |
| 05/26/2011 | WO2011062132A1 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the methods |
| 05/26/2011 | WO2011061995A1 Process for production of purified egg-yolk phospholipid composition, and pharmaceutical composition, cosmetic composition or food composition comprising purified egg-yolk phospholipid composition produced by the process |
| 05/26/2011 | WO2011061743A1 Metadoxine and derivatives thereof for use in the treatment of inflammation and immune-related disorders |
| 05/26/2011 | WO2011061725A1 Antidiabetic composition containing a plant extract of englerina lecardii |
| 05/26/2011 | WO2011061712A1 Formulations of antibody |
| 05/26/2011 | WO2011061641A2 Cooling substrates with hydrophilic containment layer and method of making |
| 05/26/2011 | WO2011061616A2 Extended release compositions containing tolterodine and process for preparing the same |
| 05/26/2011 | WO2011061519A2 Topical foam composition |
| 05/26/2011 | WO2011061516A2 Topical foam composition |
| 05/26/2011 | WO2011061498A2 Inhalation solutions |
| 05/26/2011 | WO2011061370A1 Lyophilisable vesicles without cryoprotectant |
| 05/26/2011 | WO2011061341A1 Process for the preparation of gadobenate dimeglumine complex in a solid form |
| 05/26/2011 | WO2011061298A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
| 05/26/2011 | WO2011061297A1 Method for treating retinal conditions using an intraocular tamponade |
| 05/26/2011 | WO2011061252A2 Combination therapy for treating or preventing an inflammatory skin disorder |
| 05/26/2011 | WO2011061155A1 Antifungal formulations and their use |
| 05/26/2011 | WO2011060945A2 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acid esters for the treatment of cardiovascular diseases |
| 05/26/2011 | WO2011060944A2 Active pharmaceutical ingredient capsules and polyunsaturated fatty acid esters |
| 05/26/2011 | WO2011060943A1 Pharmaceutical formulations containing beta- blocking active ingredient capsules and polyunsaturated fatty acid esters |
| 05/26/2011 | WO2011060922A1 Formulation for hgh and rhigf-1 combination |
| 05/26/2011 | WO2011060585A1 Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof |
| 05/26/2011 | WO2011060553A1 Formulation and method for rapid preparation of isotonic and cytocompatible chitosan solutions without inducing chitosan precipitation |
| 05/26/2011 | WO2011041300A4 Reduced-odor polyol composition and method of producing same |
| 05/26/2011 | WO2011036677A3 Sustained release composition of ranolazine |
| 05/26/2011 | WO2011036521A3 Formulations comprising triptan compounds |
| 05/26/2011 | WO2011028406A3 Soaking agent for the treatment of hemorrhoids and method of use |
| 05/26/2011 | WO2011024172A3 Liposomal compositions and uses of same |
| 05/26/2011 | WO2011022532A9 Methods for concomitant administration of colchicine and a second active agent |
| 05/26/2011 | WO2011011333A3 Nanomolding micron and nano scale features |
| 05/26/2011 | WO2011005714A3 Bendamustine liposomal compositions |
| 05/26/2011 | WO2011002258A3 Arginine-based amphiphilic peptide micelle |
| 05/26/2011 | WO2011002239A3 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 05/26/2011 | WO2011000581A3 Raloxifene composition |
| 05/26/2011 | WO2010136872A3 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination |
| 05/26/2011 | WO2010123472A3 Process for making a patch containing meloxicam and lornoxicam |
| 05/26/2011 | WO2010105842A3 Preparation for external application |
| 05/26/2011 | WO2010103022A3 Oil-in-water adjuvanted influenza vaccine |
| 05/26/2011 | WO2010032006A8 Treatment of adrenal insufficiency |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110125187 Light Activated Composite Tissue Adhesives |
| 05/26/2011 | US20110125109 Wound stick |
| 05/26/2011 | US20110125095 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 05/26/2011 | US20110125093 Latex medical articles for release of antimicrobial agents |
| 05/26/2011 | US20110125089 Hemostatic microspheres |
| 05/26/2011 | US20110125079 Echogenic Polymer Microcapsules and Nanocapsules and Methods for Production and Use Thereof |
| 05/26/2011 | US20110124777 Polysaccharide based network and method for the production thereof |
| 05/26/2011 | US20110124697 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/26/2011 | US20110124694 Bioavailable compositions of metaxalone and processes for producing the same |
| 05/26/2011 | US20110124691 Organic Compounds |
| 05/26/2011 | US20110123702 Room temperature-curable polymers |
| 05/26/2011 | US20110123692 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 05/26/2011 | US20110123652 Self-emulsifying active substance formulation and use of this formulation |
| 05/26/2011 | US20110123637 Protamine/rna nanoparticles for immunostimulation |
| 05/26/2011 | US20110123636 Micellic assemblies |
| 05/26/2011 | US20110123635 Method for manufacturing medicinal compounds containing dabigatran |
| 05/26/2011 | US20110123634 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123633 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123632 Nanoscale Adjuvants and Related Pharmaceutical Compositions and Methods |
| 05/26/2011 | US20110123631 Oral compositions of clindamycin |
| 05/26/2011 | US20110123630 Topical treatment of peripheral neuropathy |
| 05/26/2011 | US20110123629 Targeting of innate immune response to tumor site |
| 05/26/2011 | US20110123628 Rare earth metal compounds, methods of making, and methods of using the same |
| 05/26/2011 | US20110123627 High density compositions containing posaconazole and formulations comprising the same |
| 05/26/2011 | US20110123626 Pulmonary delivery of a fluoroquinolone |
| 05/26/2011 | US20110123625 Compositions of Less Immunogenic and Long-Circulating Protein-Lipid Complexes |
| 05/26/2011 | US20110123624 Formulations comprising aminosterols |
| 05/26/2011 | US20110123623 Rhamnolipid mechanism |
| 05/26/2011 | US20110123622 Ophthalmic formulation and method of manufacture thereof |
| 05/26/2011 | US20110123621 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 05/26/2011 | US20110123620 Silicon dioxide nanoparticles and the use thereof for vaccination |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123618 Controlled release formulation of lamotrigine |
| 05/26/2011 | US20110123617 Clioquinol for the treatment of hematological malignancies |
| 05/26/2011 | US20110123616 Calcium Carbonate Granulation |
| 05/26/2011 | US20110123615 Solid pharmaceutical composition |
| 05/26/2011 | US20110123614 Oral Dosage Forms for Delivery of Therapeutic Agents |
| 05/26/2011 | US20110123613 Extended-release dosage form |
| 05/26/2011 | US20110123612 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
| 05/26/2011 | US20110123611 Peptidyl diacylglycerides |
| 05/26/2011 | US20110123610 Extended release compositions containing tolterodine and process for preparing the same |
| 05/26/2011 | US20110123609 Multiple unit dosage form of niacin |
| 05/26/2011 | US20110123608 Pharmaceutical formulation |
| 05/26/2011 | US20110123607 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 05/26/2011 | US20110123606 Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base |
| 05/26/2011 | US20110123605 Stable digestive enzyme compositions |
| 05/26/2011 | US20110123604 Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| 05/26/2011 | US20110123603 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 05/26/2011 | US20110123602 Molecular lymphatic mapping of sentinel lymph nodes |
| 05/26/2011 | US20110123601 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 05/26/2011 | US20110123600 Use of alkylureas for treating acne |